MINNEAPOLIS, March 1 /PRNewswire-FirstCall/ -- ATS Medical, Inc. today announced that it will release financial results for the fourth quarter ended December 31, 2006 after market close on Monday, March 5, 2007. The Company will host a conference call and webcast on Monday, March 5 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the Company’s fourth quarter and full year results, and current corporate developments. The dial-in number for the conference call is 800-218-9073 for domestic participants and 303-262-2083 for international participants.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)
A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will remain available for seven days. The replay can be accessed by dialing 800-405-2236 for domestic participants and 303-590-3000 for international participants, using the passcode 11085472#. A live and archived webcast of the call can be accessed at http://www.atsmedical.com, by clicking on the Investors icon. Slides will be available in conjunction with the presentation, and can be viewed as part of the live and archived webcast.
About ATS Medical
ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The company, global in scope, has been headquartered in Minneapolis, Minnesota since its founding in 1991. More than 135,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3F(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical’s focus on cardiac surgery is further strengthened by offerings that include ATS Simulus(TM) annuloplasty products for heart valve repair, SurgiFrost(R) and FrostByte(TM) products for surgical cryoablation of cardiac arrhythmias, RTI-Cardiovascular for allograft tissue services, and the development of PARSUS blood filtration technology. The ATS Medical web site is http://www.atsmedical.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comATS Medical, Inc.
CONTACT: Michael Dale, President-CEO, +1-763-553-7736, or Michael Kramer,Senior Director of Finance, +1-763-557-2222, both of ATS Medical; orInvestors: Jennifer Beugelmans, +1-646-201-5447, or Doug Sherk,+1-415-896-6820, or Media: Steve DiMattia, +1-646-201-5445, all for ATSMedical, Inc.
Web site: http://www.atsmedical.com//
